Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Key Operating Data for the First Half of 2026

Aug 22, 2026 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Key Operating Data for the First Half of 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Nanjing Well Pharmaceutical Group Co. Ltd. Class A

"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Share Pledge and Release of Share Pledge by Shareholder Holding More Than 5% of the SharesAug 20
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business LicenseJun 10
Announcement on Implementation of Dividend Distribution for 2025May 28
Announcement on Resolutions of the 1st Meeting of the 4th Board of DirectorsMay 20

All Nanjing Well Pharmaceutical Group Co. Ltd. Class A news releases